Navigation Links
Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
Date:4/8/2013

VANCOUVER, Canada, April 8, 2013 /PRNewswire/ -- Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded the LifeSciences British Columbia Life Sciences Company of the Year Award for 2013. 

(Photo:  http://photos.prnewswire.com/prnh/20130408/SF89970)

The LifeSciences British Columbia Awards took take place on Thursday, April 4 at the Vancouver Convention Centre with several hundred guests representing the British Columbia life sciences community. 

"We are honored to be recognized by our industry peers in this way," commented Simon Pimstone , Xenon's President and CEO.  "This is the beginning of a very exciting year for Xenon.  We've worked diligently and deliberately to create strong partnerships with top tier pharmaceutical companies and to develop a deep and diverse pipeline of products.  One of Xenon's early technologies is now in an approved product to treat lipoprotein lipase deficiency, we have a late stage clinical program initiating for our novel pain medicine and an early development stage product for the treatment of anemia.  We look forward to an exciting year at Xenon as our products advance on the market and in the clinic." 

About Xenon Pharmaceuticals Inc. Xenon is a privately owned, clinical genetics-based drug discovery and development company engaged in developing novel therapies for rare diseases. For more information, visit the Company's website at http://www.xenon-pharma.com.

For more information regarding this press release, contact: Dr. Robin Sherrington , SVP Business & Corporate Development  (604) 484-3300, ddunn@xenon-pharma.com

This release contains forward-looking statements that are not based on historical fact. These forward-looking statements involve risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements.


'/>"/>
SOURCE Xenon Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Xenon Announces Appointment of EVP, Research & Development
2. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
3. SynCardias Companion 2 Driver Named a Finalist in the Medical Design Excellence Awards
4. Ultroz Elite Wearable Ultrasonic Therapy System was Named as Finalist in the 2013 Medical Design Excellence Awards
5. Nick Pace Named EVP -- Operations, Compliance, and Regulatory
6. Best Healthcare Websites of 2013 to be Named by Web Marketing Association in 17th Annual WebAward Competition
7. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
8. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
9. Steven Ek Named President and CEO of Arthrosurface
10. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
11. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... An August 3rd article on Reuters covers ... of a report in JAMA (the Journal of the American Medical Association). The study found ... to achieve BMIs under 30, when compared to patients with lower BMIs. At present, weight ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
(Date:8/16/2017)... Brentwood, TN (PRWEB) , ... August 16, 2017 ... ... market-leading dermatology practice partnerships through affiliations and de novo development, today announced ... practice. , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage ...
(Date:8/16/2017)... ... 16, 2017 , ... Paul Vitenas, MD, FACS , is honored to ... annual list identifies the nation’s top physicians, in a variety of specialties. This marks ... top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
Breaking Medicine News(10 mins):